COMMUNIQUÉS West-GlobeNewswire

Evoke Pharma Schedules Conference Call and Webcast for Third Quarter 2017 Financial Results

07/11/2017 - 14:30

SOLANA BEACH, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today that the Company will [...]

Skyline Medical Inc. Expands International Presence by Signing Distribution Agreements in Canada and Switzerland

07/11/2017 - 14:30

MINNEAPOLIS, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results

07/11/2017 - 14:30

WARREN, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for the third [...]

Biomerica Extends Exclusive License Agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019

07/11/2017 - 14:19

IRVINE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA ) today announced that it has extended its exclusive license agreement with Celtis Pharm Co. Ltd of South Korea. Celtis has changed its name [...]

ZIVO Bioscience, Inc. Annual Shareholder Meeting and Conference Call Slated for November 8, 2017 in Detroit, Michigan

07/11/2017 - 14:17

KEEGO HARBOR, Mich., Nov. 07, 2017 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc., (OTCQB:ZIVO) a Michigan-based biotech firm, invites shareholders, analysts and partners to its annual shareholder meeting on Wednesday, [...]

Galectin Therapeutics Reports 2017 Third Quarter Financial Results and Provides Business Update

07/11/2017 - 14:15

All 52 weeks of infusions and 100% of the doses have been administered in the NASH Cirrhosis, NASH-CX Phase 2b Clinical Trial Top Line Results of NASH-CX Phase 2b Clinical Trial Expected to be announced in early [...]

Genocea Presents New Data Demonstrating the Power and Versatility of its ATLAS™ Antigen Identification Platform at SITC 2017

07/11/2017 - 14:05

- ATLAS continues to demonstrate superiority to in silico methods of neoantigen identification in multiple tumor types - - ATLAS also identifies unique tumor-associated antigen response signatures in patients with lung [...]

Novan Announces Plan to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution

07/11/2017 - 14:05

MORRISVILLE, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN ) today announced that it has agreed in principle to a business structure that would enable further development [...]

Celldex Reports Third Quarter 2017 Results

07/11/2017 - 14:01

HAMPTON, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX ) today reported business and financial highlights for the third quarter ended September 30, 2017. "In late August, we completed [...]

Initial Results from Phase 2 Study of CB-839 in Combination with Opdivo® (nivolumab) to be Presented at the Society for Immunotherapy of Cancer Meeting

07/11/2017 - 14:01

Achieved confirmed responses in melanoma patients progressing on PD-1/PD-L1 therapy Expanding Bristol-Myers Squibb clinical collaboration SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Calithera [...]

HempAmericana Provides Critical Shareholder Update

07/11/2017 - 14:00

NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to provide a critical shareholder update as the Company continues to ramp operations at its Portland, Maine facility [...]

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017

07/11/2017 - 14:00

NORTHVALE, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche [...]

Immune Design Announces Multiple Presentations at CTOS and SITC Highlighting the Breadth of Existing & Future Product Candidates

07/11/2017 - 14:00

SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), a clinical-stage immunotherapy company focused on oncology, today announced seven presentations at the upcoming [...]

Atara Biotherapeutics to Participate in Four Upcoming Investor Conferences

07/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Chalice Farms Announces New Seasonal Cannabis Edibles

07/11/2017 - 14:00

Portland, Oregon-based dispensary chain, part of the Golden Leaf Holdings portfolio of brands, unveils line of Pumpkin Spice Cannabis Truffles and Cannabis-Infused Dark Chocolate Peppermint for fall and holiday season

Proteon Therapeutics Announces Third Quarter 2017 Financial Results

07/11/2017 - 14:00

WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]

Chimerix to Present at the Stifel 2017 Healthcare Conference

07/11/2017 - 14:00

DURHAM, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H., [...]

Cannabix Technologies Files THC Based Ignition Interlock Patent Application and Provides Update on Marijuana Breathalyzer Development

07/11/2017 - 14:00

VANCOUVER, British Columbia, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and [...]

Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference

07/11/2017 - 14:00

DALLAS/FORT WORTH, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR) [...]